Status:
COMPLETED
hUC Mesenchymal Stem Cells (19#iSCLife®-CSD) Therapy for Patients With Healing Poor After Uterus Injury
Lead Sponsor:
Sclnow Biotechnology Co., Ltd.
Conditions:
Uterus; Injury
Eligibility:
FEMALE
18-40 years
Phase:
PHASE1
Brief Summary
The purpose of this study is verify the efficacy and safety of Human Umbilical Cord Mesenchymal Stem Cells (UC-MSC) therapy for patients with Healing Poor after Uterus Injury, and exploring the possib...
Detailed Description
This is a random, open label, and self-control experiment. 10 patients are selected and sign consent forms, then divided into one group. Doctors collect the basic information of patient (including age...
Eligibility Criteria
Inclusion
- Female, with BMI 18-24 kg/m\^2
- Meet the clinical standard of Healing Poor After Uterus Injury
- Non smoker
- Do not accept stem cells treatment in 6 months
- Participants or their family members sign the consent form of this study
Exclusion
- Pregnant or breast feeding women
- Age \<18 or \>40
- Refuse to sign the consent form
- Patients with underlying risk of medical disease history: history of diabetes, serious cardiovascular disease, severe infection, alimentary tract hemorrhage, etc.
- Serum with HIV, syphilis antibody positive
- Severe mental disease, cognitive disorder patients
- Other severe system or organ organic disease
- Participate other clinical experiments in 3 months
- Ovarian and pituitary dysfunction diseases
- With some other conditions that doctor propose not to participate
Key Trial Info
Start Date :
October 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 21 2021
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03386708
Start Date
October 1 2018
End Date
September 21 2021
Last Update
February 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xiangya Hospital Central South University
Changsha, Hunan, China, 410008